114 results
Page 2 of 6
8-K
EX-99.1
ivwvznqaoonvn4b3g1li
31 Mar 23
Processa Pharmaceuticals Provides Corporate Update and Announces Year End 2022 Financial Results
8:30am
8-K
EX-99.1
i67o60q 01qepa8cr
8 Nov 22
Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.1
cp4pfjnch7rp0ucgalp9
12 Aug 22
Processa Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update
10:35am
8-K
EX-10.1
rvlsibph5 da11h8ui
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
424B5
77phyc3x dwaa4
24 Mar 22
Prospectus supplement for primary offering
4:15pm
8-K
EX-3.1
ree pt1r2
6 Jan 22
Material Modifications to Rights of Security Holders
2:36pm
PRE 14A
pbbh7gsn4wgbgxfgh
1 Sep 21
Preliminary proxy
4:46pm
424B5
hxwilvqus
20 Aug 21
Prospectus supplement for primary offering
4:46pm